Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 10Recruiting 3Unknown 2Terminated 2Not yet recruiting 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2Other hematologic neoplasm 1Lymphoid 1Head & Neck 1

Conditions

Breast Neoplasms 542Triple Negative Breast Neoplasms 86Neoplasms 18Colorectal Neoplasms 18Lung Neoplasms 16Neoplasm Metastasis 15Advanced Breast Cancer 15Prostatic Neoplasms 14Carcinoma, Non-Small-Cell Lung 14Motor Activity 12Breast Cancer Lymphedema 12HER2-positive Breast Cancer 11Uterine Cervical Neoplasms 10Stomach Neoplasms 10Ovarian Neoplasms 10Endometrial Neoplasms 10Carcinoma, Intraductal, Noninfiltrating 10Anxiety Disorders 10Depression 8Brain Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Pain, Postoperative 6Pain 6Melanoma 6Lymphedema 6Head and Neck Neoplasms 6Colonic Neoplasms 6Cardiotoxicity 6Pancreatic Neoplasms 5Liver Neoplasms 5

Interventions

Furosemide 1Duloxetine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Drug-Related Side Effects and Adverse Reactions × Breast × Clear all
NCT07264985 2025-12-04

Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib

Hubei Cancer Hospital

Not yet recruiting
60 enrolled
Breast

Breast Neoplasms, Diarrhea, Drug-Related Side Effects and Adverse Reactions

NCT06407401 2024-11-05

Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Not yet recruiting
399 enrolled
Breast

Breast Neoplasms, Musculoskeletal Pain, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡